UBI Pharma Inc. (UBIP) is the first pharmaceutical company in Asia to pass US FDA inspection for its sterile injectable production line, having successfully launched multiple injectable products in the US market. Beyond contract manufacturing services, UBI Pharma developed a successful business model in 2018 to offer professional one-stop CDMO services, quickly turning ideas into products by taking clients' projects from laboratory to clinic.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen